Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Einstein (Sao Paulo). 2021 May 24;19:eRC5488. doi: 10.31744/einstein_journal/2021RC5488. eCollection 2021.
Histoplasmosis is an infection caused by the dimorphic fungus Histoplasma capsulatum. The disease is endemic in several regions of tropical and temperate climate. The fungus presents opportunistic behavior, causing widespread infection in immunocompromised patients, resulting from complication of primary pulmonary infection, due to exogenous reinfection or reactivation of a quiescent source. In immunocompetent individuals, approximately 95% of pulmonary infections are asymptomatic. However, prolonged exposure to high amount spores may lead to acute or chronic lung infection. Due to the low amount of inoculum, primary cutaneous histoplasmosis caused by traumatic implantation is extremely rare and effectively treated with triazoles. Thus, the present study aims to report a case of primary cutaneous histoplasmosis that is difficult to treat in an immunocompetent patient, and to review the literature on the incidence of drug-resistant Histoplasma capsulatum strains in clinical practice.
组织胞浆菌病是由二相性真菌荚膜组织胞浆菌引起的感染。该疾病在地中海气候和热带气候的几个地区流行。真菌具有机会性,在免疫功能低下的患者中引起广泛感染,导致原发性肺部感染的并发症,这是由于外源性再感染或潜伏源的重新激活。在免疫功能正常的个体中,约 95%的肺部感染无症状。然而,长时间暴露于高浓度孢子可能导致急性或慢性肺部感染。由于接种物数量少,创伤性植入引起的原发性皮肤组织胞浆菌病极为罕见,且三唑类药物治疗有效。因此,本研究旨在报告一例免疫功能正常患者中难以治疗的原发性皮肤组织胞浆菌病,并复习文献中关于临床实践中耐药物荚膜组织胞浆菌菌株的发生率。